Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (492) 492
cutaneous angiosarcoma (382) 382
index medicus (325) 325
female (294) 294
angiosarcoma (263) 263
dermatology (247) 247
male (233) 233
aged (232) 232
middle aged (201) 201
skin neoplasms - pathology (186) 186
skin (178) 178
hemangiosarcoma - pathology (168) 168
pathology (158) 158
oncology (154) 154
surgery (138) 138
adult (135) 135
aged, 80 and over (135) 135
immunohistochemistry (125) 125
cancer (124) 124
radiotherapy (117) 117
prognosis (109) 109
scalp (103) 103
tumors (99) 99
diagnosis (88) 88
diagnosis, differential (82) 82
hemangiosarcoma - diagnosis (77) 77
carcinoma (74) 74
hemangiosarcoma - therapy (74) 74
sarcoma (73) 73
soft-tissue (72) 72
head (70) 70
metastasis (69) 69
skin neoplasms - diagnosis (69) 69
treatment outcome (68) 68
chemotherapy (66) 66
retrospective studies (62) 62
melanoma (58) 58
care and treatment (57) 57
neck (57) 57
face (54) 54
skin neoplasms - therapy (54) 54
hemangiosarcoma - surgery (53) 53
radiation (53) 53
of-the-literature (52) 52
radiation-therapy (51) 51
combined modality therapy (50) 50
hemangiosarcoma - etiology (47) 47
medicine & public health (45) 45
biopsy (44) 44
therapy (44) 44
risk factors (43) 43
skin neoplasms - metabolism (43) 43
breast cancer (42) 42
cutaneous (42) 42
biomarkers, tumor - analysis (41) 41
breast (41) 41
breast neoplasms - radiotherapy (40) 40
hemangiosarcoma - drug therapy (39) 39
soft-tissue sarcoma (39) 39
adolescent (38) 38
analysis (38) 38
breast neoplasms - pathology (37) 37
head and neck neoplasms - pathology (37) 37
radiation therapy (37) 37
animals (35) 35
neoplasms (35) 35
hemangiosarcoma - mortality (34) 34
neoplasm staging (34) 34
paclitaxel (34) 34
skin cancer (34) 34
soft-tissue sarcomas (34) 34
kaposis-sarcoma (33) 33
lymphedema (33) 33
skin neoplasms - etiology (33) 33
epithelioid angiosarcoma (32) 32
expression (32) 32
scalp - pathology (32) 32
case report (31) 31
prognostic-factors (31) 31
skin neoplasms - surgery (31) 31
tumor (31) 31
health aspects (30) 30
skin diseases (30) 30
skin neoplasms - secondary (30) 30
radiotherapy - adverse effects (29) 29
cutaneous melanoma (28) 28
hemangiosarcoma - metabolism (28) 28
neoplasms, radiation-induced - pathology (28) 28
survival rate (28) 28
abridged index medicus (27) 27
angiogenesis (27) 27
antineoplastic agents - therapeutic use (27) 27
breast neoplasms - surgery (27) 27
breast neoplasms - therapy (27) 27
child (27) 27
lumpectomy (27) 27
squamous-cell carcinoma (27) 27
atypical vascular-lesions (26) 26
follow-up studies (26) 26
hemangiosarcoma - secondary (26) 26
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (23) 23
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Credit Valley Hospital - Online (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (722) 722
German (26) 26
Korean (12) 12
French (11) 11
Spanish (5) 5
Chinese (1) 1
Japanese (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Angiosarcoma
by Young, Robin J, Dr and Brown, Nicola J, Prof and Reed, Malcolm W, Prof and Hughes, David, FRCPath and Woll, Penella J, Prof
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 983 - 991
Summary Angiosarcomas are rare soft-tissue sarcomas of endothelial cell origin that have a poor prognosis. They can arise anywhere in the body, most commonly... 
Hematology, Oncology and Palliative Medicine | BREAST-CANCER | PHASE-II TRIAL | SOFT-TISSUE SARCOMAS | PROGNOSTIC-FACTORS | ONCOLOGY | TREATMENT OUTCOMES | CUTANEOUS ANGIOSARCOMA | VINYL-CHLORIDE | HEPATIC ANGIOSARCOMA | CLINICAL-FEATURES | OF-THE-LITERATURE | Hemangiosarcoma - therapy | Hemangiosarcoma - pathology | Predictive Value of Tests | Diagnosis, Differential | Hemangiosarcoma - etiology | Humans | Risk Factors | Male | Treatment Outcome | Hemangiosarcoma - genetics | Hemangiosarcoma - diagnosis | Female | Neoplasm Staging | Angiosarcoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Angiosarcoma: Clinical and molecular insights
by Lahat, Guy and Dhuka, Asha R and Hallevi, Hen and Xiao, Lianchun and Zou, Changye and Smith, Kerrington D and Phung, Thuy L and Pollock, Raphael E and Benjamin, Robert and Hunt, Kelly K and Lazar, Alexander J and Lev, Dina
Annals of Surgery, ISSN 0003-4932, 06/2010, Volume 251, Issue 6, pp. 1098 - 1106
Objective: Angiosarcoma (AS) is a rare understudied soft tissue sarcoma exhibiting endothelial cell differentiation. We sought to evaluate AS natural history... 
SURGERY | PHASE-II TRIAL | PROGNOSTIC-FACTORS | CUTANEOUS ANGIOSARCOMA | C-KIT | MUTATIONS | EXPRESSION | SOFT-TISSUE SARCOMA | BREAST | ENDOTHELIAL GROWTH-FACTOR | PACLITAXEL | Immunohistochemistry | Hemangiosarcoma - metabolism | Prognosis | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - metabolism | Phosphotransferases - antagonists & inhibitors | Phosphoproteins - metabolism | Proto-Oncogene Proteins c-kit - metabolism | DNA-Binding Proteins - metabolism | Young Adult | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Microarray Analysis | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-akt - metabolism | Hemangiosarcoma - therapy | Hemangiosarcoma - pathology | Biomarkers, Tumor - analysis | Neoplasm Recurrence, Local | Survival Rate | Combined Modality Therapy | Hemangiosarcoma - mortality | Transcription Factors - metabolism | Adolescent | Aged | Benzamides | Adaptor Proteins, Signal Transducing - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Terminal Bleeding in Angiosarcoma
by Gill, Jaya M and Madden, Brian and Frost, Janice and Crane-Okada, Rebecca and Hulsman, Robert L and Elliott, Kristen and Saria, Marlon G
Journal of Palliative Medicine, ISSN 1096-6218, 08/2019, Volume 22, Issue 8, pp. 19 - 1013
Introduction: Terminal bleeding, a distressing symptom experience for patients, caregivers, and health professionals, occurs in a subset of patients in the... 
Case Discussions in Palliative Medicine | HEAD | bleeding | complications | SCALP | HEMORRHAGE | CUTANEOUS ANGIOSARCOMA | SOFT-TISSUE | CANCER | LIPOSOMAL DOXORUBICIN | management | HEALTH CARE SCIENCES & SERVICES | angiosarcoma | QUALITY-OF-LIFE | NECK
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cutaneous Angiosarcoma
by Rampinelli, Heloisa and Ramos-e-Silva, Marcia and Quintella, Danielle Carvalho and Fernandes, Nurimar Conceição
Case Reports in Dermatology, ISSN 1662-6567, 03/2018, Volume 10, Issue 1, pp. 55 - 60
Cutaneous angiosarcoma is a rare malignant tumor showing blood or lymphatic vessel differentiation, corresponding to < 2% of all sarcomas. It preferably... 
Single Case | Cutaneous neoplasia | Hemangiosarcoma | Lymphedema | Sarcoma | Lymphangiosarcoma | Lymphatic system | Chemotherapy | Medical imaging | Dermatology | Medical prognosis | Metastasis | Radiation therapy | Patients | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Angiosarcoma of the Scalp and Face: The Mayo Clinic Experience
by Patel, Samir H and Hayden, Richard E and Hinni, Michael L and Wong, William W and Foote, Robert L and Milani, Shadi and Wu, Qing and Ko, Stephen J and Halyard, Michele Y
JAMA Otolaryngology–Head & Neck Surgery, ISSN 2168-6181, 04/2015, Volume 141, Issue 4, pp. 335 - 340
IMPORTANCE: The etiology and optimal treatment are unknown for angiosarcoma, an aggressive malignant tumor that affects vascular endothelial cells and can be... 
HEAD | PROGNOSIS | OTORHINOLARYNGOLOGY | CUTANEOUS ANGIOSARCOMA | SINGLE-INSTITUTION | NECK | OUTCOMES | Facial Neoplasms - mortality | Age Factors | Humans | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Skin Neoplasms - mortality | Female | Retrospective Studies | Hemangiosarcoma - therapy | Skin Neoplasms - pathology | Hemangiosarcoma - pathology | Facial Neoplasms - therapy | Skin Neoplasms - therapy | Head and Neck Neoplasms - therapy | Survival Rate | Treatment Outcome | Combined Modality Therapy | Hemangiosarcoma - mortality | Head and Neck Neoplasms - pathology | Disease-Free Survival | Scalp | Aged | Head and Neck Neoplasms - mortality | Facial Neoplasms - pathology | Care and treatment | Usage | Chemotherapy | Angiosarcoma | Radiotherapy | Risk factors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cutaneous angiosarcoma: a current update
by Shustef, Elina and Kazlouskaya, Viktoryia and Prieto, Victor G and Ivan, Doina and Aung, Phyu P
Journal of Clinical Pathology, ISSN 0021-9746, 11/2017, Volume 70, Issue 11, pp. 917 - 925
Cutaneous angiosarcoma (cAS) is a rare malignant neoplasm with variable clinical presentation. Although a distinct vascular tumour, cAS shares many overlapping... 
angiosarcoma | histopathology | cutaneous vascular lesions | immunohistochemistry | molecular and therapy | histologic mimickers | ANTI-MYC IMMUNOHISTOCHEMISTRY | WEEKLY PACLITAXEL | EPITHELIOID ANGIOSARCOMA | ARTERIOVENOUS-FISTULA | FOAMY CELL ANGIOSARCOMA | PHASE-II | PATHOLOGY | SOFT-TISSUE | METRONOMIC CHEMOTHERAPY | PROGNOSTIC FEATURES | ATYPICAL VASCULAR-LESIONS | Hemangiosarcoma - therapy | Immunohistochemistry | Skin Neoplasms - pathology | Hemangiosarcoma - pathology | Predictive Value of Tests | Diagnosis, Differential | Genetic Predisposition to Disease | Skin Neoplasms - therapy | Biomarkers, Tumor - analysis | Humans | Risk Factors | Skin Neoplasms - chemistry | Treatment Outcome | Hemangiosarcoma - genetics | Hemangiosarcoma - chemistry | Molecular Diagnostic Techniques | Phenotype | Biopsy | Skin Neoplasms - genetics | Biomarkers, Tumor - genetics | Neoplasm Staging | Care and treatment | Genetic aspects | Diagnosis | Research | Angiosarcoma | Epithelial tumors | Angiogenesis | Chemotherapy | Lymphedema | Medical prognosis | Genes | Breast cancer | Metastasis | Mutation | Radiation therapy | Cancer therapies | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Angiosarcoma outcomes and prognostic factors: A 25-year single institution experience
by Buehler, Darya and Rice, Stephanie R and Moody, John S and Rush, Patrick and Hafez, Gholam-Reza and Attia, Steven and Longley, B. Jack and Kozak, Kevin R
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 2013, Volume 37, Issue 5, pp. 473 - 479
Objective: Angiosarcoma is an aggressive malignancy with endothelial differentiation and notoriously poor prognosis despite aggressive therapy. Limited data... 
Sarcoma | Angiosarcoma | Retrospective study | sarcoma | SOFT-TISSUE SARCOMAS | SCALP | CUTANEOUS ANGIOSARCOMA | SORAFENIB | RADIATION | BREAST | MOHS MICROGRAPHIC SURGERY | WEEKLY PACLITAXEL | PHASE-II TRIAL | ONCOLOGY | angiosarcoma | CANCER-CENTERS | retrospective study | Hemangiosarcoma - therapy | Hemangiosarcoma - pathology | Prognosis | Soft Tissue Neoplasms - mortality | Humans | Middle Aged | Male | Survival Rate | Hemangiosarcoma - mortality | Young Adult | Soft Tissue Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Wisconsin | Soft Tissue Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Early Breast Angiosarcoma Development After Radiotherapy: A Cautionary Tale
by Wei, Nicholas J J and Crowley, Timothy P and Ragbir, Maniram
Annals of Plastic Surgery, ISSN 0148-7043, 08/2019, Volume 83, Issue 2, pp. 152 - 153
ABSTRACTThis is a short clinical report depicting an exceptionally early presentation of radiation-induced angiosarcoma and overview of the literature. This... 
SURGERY | cutaneous bruising | MULTICENTER | THERAPY | radiation induced | secondary angiosarcoma | angiosarcoma | CANCER | breast conserving therapy | SOFT-TISSUE SARCOMA | Complications and side effects | Development and progression | Care and treatment | Breast cancer | Radiotherapy | Angiosarcoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Case 242: Radiation-induced Angiosarcoma
by Disharoon, M and Kozlowski, KF and Kaniowski, JM
RADIOLOGY, ISSN 0033-8419, 06/2017, Volume 283, Issue 3, pp. 908 - 915
History In 2004, this woman received a diagnosis of invasive mammillary carcinoma, tubular variant, strongly positive for estrogen and progesterone receptors.... 
BREAST-CANCER | THERAPY | SARCOMA | CUTANEOUS ANGIOSARCOMA | RISK | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | FEATURES | Breast Neoplasms - radiotherapy | Hemangiosarcoma - etiology | Humans | Neoplasms, Radiation-Induced - etiology | Female | Skin Neoplasms - etiology | Neoplasms, Second Primary - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The Management and Prognosis of Facial and Scalp Angiosarcoma: A Retrospective Analysis of 15 Patients
by Alqumber, Nedhal A and Choi, Jong-Woo and Kang, Min-kyu
Annals of Plastic Surgery, ISSN 0148-7043, 07/2019, Volume 83, Issue 1, pp. 55 - 62
BACKGROUNDAngiosarcomas are extremely aggressive malignant tumors that arise from vascular endothelial cells. The risk factors, etiology, prognostic factors,... 
SURGERY | HEAD | SOFT-TISSUE SARCOMAS | BEVACIZUMAB | CUTANEOUS ANGIOSARCOMA | resection | chemotherapy | RADIATION-THERAPY | NEOADJUVANT CHEMOTHERAPY | radiation | scalp | angiosarcoma | RADIOTHERAPY | EXPRESSION | FACE | UTILITY | Head and neck tumors | Care and treatment | Prognosis | Angiosarcoma | Statistics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Angiosarcoma Arising in Chronic Expanding Hematoma: Five Cases of an Underrecognized Association
by Burgert-Lon, Christine E and Riddle, Nicole D and Lackman, Richard D and Evenski, Andrea J and Brooks, John S J
The American Journal of Surgical Pathology, ISSN 0147-5185, 11/2015, Volume 39, Issue 11, pp. 1540 - 1547
Little is known about the etiology or pathogenesis of angiosarcoma (AS). We describe a series of 5 cases of AS arising in chronic expanding hematomas.... 
Angiosarcoma | Pathogenesis | Chronic expanding hematoma | Postradiation sarcoma | Chronic hematomas | SURGERY | SITE | EPITHELIOID ANGIOSARCOMA | CUTANEOUS ANGIOSARCOMA | GRAFT | PATHOLOGY | SOFT-TISSUE | LESION | SECONDARY ANGIOSARCOMA | pathogenesis | postradiation sarcoma | MYC AMPLIFICATION | ARTERIOVENOUS-FISTULA | angiosarcoma | chronic hematomas | chronic expanding hematoma | Hemangiosarcoma - therapy | Immunohistochemistry | Proto-Oncogene Proteins c-myc - analysis | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Humans | Middle Aged | Hematoma - surgery | Male | Treatment Outcome | Hemangiosarcoma - chemistry | Magnetic Resonance Imaging | Soft Tissue Neoplasms - chemistry | Time Factors | Biopsy | Hematoma - pathology | Fatal Outcome | Soft Tissue Neoplasms - pathology | Adult | Female | Aged | Hemangiosarcoma - secondary | Chronic Disease | Soft Tissue Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion
by Lucas, David R
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 11/2009, Volume 133, Issue 11, pp. 1804 - 1809
Angiosarcoma, one of the least common sarcomas, has become increasingly important because of its association with radiation therapy, especially for breast... 
BREAST-CANCER | SURGERY | MEDICINE, RESEARCH & EXPERIMENTAL | THERAPY | SARCOMA | CUTANEOUS ANGIOSARCOMA | SKIN | MEDICAL LABORATORY TECHNOLOGY | PATHOLOGY | Skin Neoplasms - pathology | Hemangiosarcoma - pathology | Hemangioma - pathology | Vascular Diseases - pathology | Biomarkers, Tumor - analysis | Hemangiosarcoma - etiology | Humans | Skin Neoplasms - chemistry | Neoplasms, Radiation-Induced - chemistry | Hemangiosarcoma - chemistry | Hemangioma - chemistry | Skin - blood supply | Breast Neoplasms - radiotherapy | Female | Skin Neoplasms - etiology | Neoplasms, Radiation-Induced - pathology | Complications and side effects | Care and treatment | Usage | Biopsy | Patient outcomes | Breast cancer | Diagnosis | Angiosarcoma | Radiotherapy | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Angiosarcoma: State of the art and perspectives
by Penel, Nicolas and Marréaud, Sandrine and Robin, Yves-Marie and Hohenberger, Peter
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2010, Volume 80, Issue 2, pp. 257 - 263
Abstract We propose a literature review of available data on angiosarcoma (AS). AS account for 1% of adult soft tissue sarcoma. Two risk factors are... 
Hematology, Oncology and Palliative Medicine | Angiogenesis | Weekly paclitaxel | Angiosarcoma | Prognostic factors | METRONOMIC TROFOSFAMIDE | PROGNOSTIC-FACTORS | PHASE-II | CUTANEOUS ANGIOSARCOMA | VINYL-CHLORIDE | BREAST-CANCER | LYMPH-NODE METASTASIS | ONCOLOGY | HEMATOLOGY | TRANSCRIPTION FACTOR | SOFT-TISSUE SARCOMA | ENDOTHELIAL GROWTH-FACTOR | Doxorubicin - therapeutic use | Hemangiosarcoma - pathology | Taxoids - therapeutic use | Bridged-Ring Compounds - therapeutic use | Animals | Hemangiosarcoma - epidemiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hemangiosarcoma - drug therapy | Humans | Antineoplastic Agents - therapeutic use | Chemotherapy | Anthracyclines | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text CD8+tumor‐infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
by Fujii, Hiroko and Arakawa, Akiko and Utsumi, Daisuke and Sumiyoshi, Shinji and Yamamoto, Yosuke and Kitoh, Akihiko and Ono, Masahiro and Matsumura, Yumi and Kato, Mayumi and Konishi, Keisuke and Shiga, Takeo and Sano, Shigetoshi and Sakaguchi, Shimon and Miyagawa‐Hayashino, Aya and Takahashi, Kenzo and Uezato, Hiroshi and Miyachi, Yoshiki and Tanioka, Miki
International Journal of Cancer, ISSN 0020-7136, 05/2014, Volume 134, Issue 10, pp. 2393 - 2402
Tumor‐infiltrating lymphocytes (TILs) have been reported as a prognostic factor in various cancers and are a promising target for immunotherapy. To investigate... 
cutaneous angiosarcoma | prognosis | tumor‐infiltrating lymphocytes | tumor-infiltrating lymphocytes | Forkhead Transcription Factors - immunology | Immunohistochemistry | Leukocytes, Mononuclear - metabolism | Hemangiosarcoma - metabolism | CD8-Positive T-Lymphocytes - pathology | Prognosis | Humans | Middle Aged | Ki-67 Antigen - metabolism | Male | Interferon-gamma - metabolism | Ki-67 Antigen - immunology | Forkhead Transcription Factors - metabolism | Leukocytes, Mononuclear - immunology | Aged, 80 and over | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Leukocyte Count | Retrospective Studies | Skin Neoplasms - pathology | CD4 Antigens - immunology | Hemangiosarcoma - pathology | Skin Neoplasms - immunology | Kaplan-Meier Estimate | Lymphatic Metastasis | CD8 Antigens - immunology | Skin Neoplasms - metabolism | Leukocytes, Mononuclear - pathology | CD8 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Hemangiosarcoma - immunology | Interferon-gamma - immunology | Aged | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | CD4 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - immunology | Angiosarcoma | Lymphocytes | Medical prognosis | Cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text MRI findings of radiation‐associated angiosarcoma of the breast (RAS)
by Chikarmane, Sona A and Gombos, Eva C and Jagadeesan, Jayender and Raut, Chandrajit and Jagannathan, Jyothi P
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 09/2015, Volume 42, Issue 3, pp. 763 - 770
Purpose To describe the magnetic resonance imaging (MRI) characteristics of radiation‐associated breast angiosarcomas (RAS). Materials and Methods In this... 
angiosarcoma | breast magnetic resonance imaging | radiation‐associated | radiation-associated | DIAGNOSIS | THERAPY | IMAGING FINDINGS | CUTANEOUS ANGIOSARCOMA | RISK | RADIOTHERAPY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SECONDARY ANGIOSARCOMA | Hemangiosarcoma - pathology | Hemangiosarcoma - etiology | Humans | Middle Aged | Ultrasonography, Mammary | Breast Neoplasms - etiology | Mammography | Radiotherapy - adverse effects | Hemangiosarcoma - diagnosis | Breast Neoplasms - complications | Magnetic Resonance Imaging | Breast Neoplasms - radiotherapy | Neoplasms, Radiation-Induced - diagnosis | Image Processing, Computer-Assisted | Breast Neoplasms - pathology | Aged, 80 and over | Adult | Contrast Media - chemistry | Female | Aged | Breast Neoplasms - diagnosis | Retrospective Studies | Neoplasms, Radiation-Induced - pathology | Breast - pathology | Chemotherapy | Magnetic resonance imaging | Angiosarcoma | Radiation | Cancer | Ultrasonic imaging | Breast cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab
by Jeng, Michael R and Fuh, Beng and Blatt, Julie and Gupta, Anita and Merrow, Arnold C and Hammill, Adrienne and Adams, Denise
Pediatric Blood & Cancer, ISSN 1545-5009, 11/2014, Volume 61, Issue 11, pp. 2115 - 2117
We describe a child initially diagnosed with multi‐focal infantile hemangioma (cutaneous, hepatic, pulmonary), a benign vascular lesion, which underwent... 
angiosarcoma | bevacizumab | KRAS L19F | malignant transformation | PROPRANOLOL | ONCOLOGY | LIVER | TISSUE | CUTANEOUS ANGIOSARCOMA | PEDIATRICS | HEMATOLOGY | Hemangiosarcoma - pathology | Hemangioma - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Cell Transformation, Neoplastic | Hemangiosarcoma - drug therapy | Humans | Angiogenesis Inhibitors - therapeutic use | Infant | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Antimitotic agents | Chemotherapy | Development and progression | Angiosarcoma | Antineoplastic agents | Vascular endothelial growth factor | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights